Cilostazol Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with cilostazol
K
- Kabikinase (streptokinase)
- Kadcyla (ado-trastuzumab emtansine)
- Kaletra (lopinavir / ritonavir)
- Kalydeco (ivacaftor)
- Kao-Paverin (loperamide)
- Kaopectate 1-D (loperamide)
- Kaopectate II (loperamide)
- Katerzia (amlodipine)
- Kengreal (cangrelor)
- ketamine / ketoprofen / lidocaine topical
- ketamine / midazolam / ondansetron
- Ketek (telithromycin)
- Ketek Pak (telithromycin)
- ketoconazole
- ketoprofen
- ketoprofen / lidocaine topical
- ketorolac
- ketorolac ophthalmic
- ketorolac / phenylephrine ophthalmic
- ketorolac / phenylephrine / proparacaine / tropicamide ophthalmic
- Khedezla (desvenlafaxine)
- Kimmtrak (tebentafusp)
- Kinlytic (urokinase)
- Kiprofen (ketoprofen)
- Kisqali (ribociclib)
- Kisqali Femara Co-Pack (letrozole / ribociclib)
- Kisunla (donanemab)
- Klofensaid II (diclofenac topical)
- Kondremul (mineral oil)
- Kondremul Plain (mineral oil)
- Kondremul with Phenolphtalein (mineral oil / phenolphthalein)
- Konvomep (omeprazole / sodium bicarbonate)
- Kori Krill Oil Omega-3 (omega-3 polyunsaturated fatty acids)
- Korlym (mifepristone)
- Koselugo (selumetinib)
- Krazati (adagrasib)
- Kristalose (lactulose)
- Kybella (deoxycholic acid)
- Kynmobi (apomorphine)
- Kytril (granisetron)
More about cilostazol
- cilostazol consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (15)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous cardiovascular agents
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.